These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9828668)

  • 1. [Which form of therapy (insulin therapy or oral antidiabetics) is best for a patient with newly diagnosed type 2 diabetes mellitus?].
    Lehmann R
    Praxis (Bern 1994); 1998 Oct; 87(41):1368-9. PubMed ID: 9828668
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive insulin therapy in newly diagnosed type 2 diabetes.
    Retnakaran R; Drucker DJ
    Lancet; 2008 May; 371(9626):1725-6. PubMed ID: 18502278
    [No Abstract]   [Full Text] [Related]  

  • 3. Exenatide therapy in insulin-treated type 2 diabetes and obesity.
    Nayak UA; Govindan J; Baskar V; Kalupahana D; Singh BM
    QJM; 2010 Sep; 103(9):687-94. PubMed ID: 20624837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inefficacy of oral antidiabetics: failure or natural history of diabetes?].
    Schönenweid C
    Rev Med Suisse Romande; 1995 Sep; 115(9):671-3. PubMed ID: 7481353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications for a favourable effect of intensive insulin therapy for newly-diagnosed type 2 diabetes].
    Roep BO; Pijl H
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2378-80. PubMed ID: 19055134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of diabetes mellitus in older patients: pill or pen?].
    Erkelens DW
    Ned Tijdschr Geneeskd; 1989 Jun; 133(22):1107-9. PubMed ID: 2662030
    [No Abstract]   [Full Text] [Related]  

  • 9. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
    Leutenegger M; Bertin E; Grulet H
    Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
    [No Abstract]   [Full Text] [Related]  

  • 10. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2.
    Pagkalos EM
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S100-1. PubMed ID: 21864738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Approach to diabetes therapy. 2. Selection and the use of oral antidiabetics. 2) Agents to correct insulin resistance].
    Kashiwagi A; Maegawa H
    Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1530-5. PubMed ID: 11062900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy with oral antidiabetics 1983].
    Berchtold P; Berger M
    Ther Umsch; 1983 Oct; 40(10):883-90. PubMed ID: 6359559
    [No Abstract]   [Full Text] [Related]  

  • 16. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
    Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct healthcare costs and clinical outcomes after insulin initiation in patients with type 2 diabetes mellitus in Spain: 24-month follow-up data from the INSTIGATE study.
    Dilla T; Nicolay C; Alvarez M; Reviriego J; Goday A; Castell C
    Endocrinol Nutr; 2013 May; 60(5):224-34. PubMed ID: 23528647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncomplicating insulin therapy: strategies for initiation in patients with type 2 diabetes.
    Kapustin JF
    Adv NPs PAs; 2012 May; 3(5):20-6; quiz 27. PubMed ID: 22670303
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 2 diabetes: the role of basal insulin therapy.
    LeRoith D; Levetan CS; Hirsch IB; Riddle MC
    J Fam Pract; 2004 Mar; 53(3):215-22. PubMed ID: 15000929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D
    Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.